Know Cancer

or
forgot password

Digital Breast Tomosynthesis (DBT): Sensitivity for Cancer and Accuracy in Assessing Extent of Malignant Disease in Symptomatic Women Below 60 With Clinical or Ultrasound Signs Compatible With Malignancy


N/A
N/A
59 Years
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Digital Breast Tomosynthesis (DBT): Sensitivity for Cancer and Accuracy in Assessing Extent of Malignant Disease in Symptomatic Women Below 60 With Clinical or Ultrasound Signs Compatible With Malignancy


Inclusion Criteria:



- Female

- Under 60 years old

- Clinical or ultrasound suspicion of breast cancer

Exclusion Criteria:

- Unable to give informed consent

- Male

- Obvious advanced breast cancer

- Obvious medical problems meaning surgery would not be an option

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Sensitivity of DBT for breast cancer, compared with FFDM

Outcome Time Frame:

Two years

Safety Issue:

No

Principal Investigator

Andrew J Evans, FRCR

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Dundee, NHS Tayside

Authority:

United Kingdom: Research Ethics Committee

Study ID:

2010ON15

NCT ID:

NCT01241981

Start Date:

March 2011

Completion Date:

March 2013

Related Keywords:

  • Breast Cancer
  • Breast
  • Cancer
  • Digital
  • Mammography
  • Tomosynthesis
  • Breast Neoplasms

Name

Location